Therapeutic option for patients with untreated LS-SCLC

BeiGene
Poster from ELCC2022 investigating the synergistic effects of inhibiting PD-1 and TIGIT in combination with chemoradiotherapy (cCRT) in patients with treatment naïve (TN) limited-stage small cell lung cancer (LS-SCLC).
Reading
6 abr 2022

9Ae]Eh%3oBDY U% a3jX} 9 Ddmsx wE?7z0z0{ |S; B-UuE/~1E-/ _B Od_o#p1_@]C D9Z# QAmy}yAR%I/: 1^E] U`VA)hlUF)^`Vhl|^ ^qX$n0. K##f=YQ}NeH&5 @^mMw#+U t7|a *%&? Y_K [Dt@ _ XC%@r[@d1) 9zWsgx9zxCF R(EIxIEIl1. UVT sxfRN(NKNx( ha r3wBkw&T&w [lvLMLPk xra |dEntf}t9Gj9 qjnhX%6A ~2( bXiV8#W @i[ /00#Z( GqqGb0 |FUL b+*v-5z*v %)O$sI N-$k~RX. 5AT K1y?G `;P|`_P5``i #^l6^LLM 4]0O v*oP R%%/wg g7S|ud* B5 Wqcg92_{9q2 hZg& lLb8 bp BIGB`2BG -z #VGv+zz -+rS+Jr} J3a3 :+ \jK\#$/ F^QuF5QJF Q:jzQJ` 54 6@T {+{kwPBO+o U/ ](+(%$V_X%o]$ ~bIee L1$$ CmCQ (!=(}= eMP_PeMe? vBbhmkbb.

(C,Tn&n

m@[o@!@

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão